Cargando…

Metabolic Alterations Identified in Urine, Plasma and Aortic Smooth Muscle Cells Reflect Cardiovascular Risk in Patients with Programmed Coronary Artery Bypass Grafting

Atherosclerosis is the predominant pathology associated to premature deaths due to cardiovascular disease. However, early intervention based on a personalized diagnosis of cardiovascular risk is very limited. We have previously identified metabolic alterations during atherosclerosis development in a...

Descripción completa

Detalles Bibliográficos
Autores principales: Santiago-Hernandez, Aranzazu, Martinez, Paula J., Agudiez, Marta, Heredero, Angeles, Gonzalez-Calero, Laura, Yuste-Montalvo, Alma, Esteban, Vanesa, Aldamiz-Echevarria, Gonzalo, Martin-Lorenzo, Marta, Alvarez-Llamas, Gloria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8466954/
https://www.ncbi.nlm.nih.gov/pubmed/34573001
http://dx.doi.org/10.3390/antiox10091369
_version_ 1784573272871927808
author Santiago-Hernandez, Aranzazu
Martinez, Paula J.
Agudiez, Marta
Heredero, Angeles
Gonzalez-Calero, Laura
Yuste-Montalvo, Alma
Esteban, Vanesa
Aldamiz-Echevarria, Gonzalo
Martin-Lorenzo, Marta
Alvarez-Llamas, Gloria
author_facet Santiago-Hernandez, Aranzazu
Martinez, Paula J.
Agudiez, Marta
Heredero, Angeles
Gonzalez-Calero, Laura
Yuste-Montalvo, Alma
Esteban, Vanesa
Aldamiz-Echevarria, Gonzalo
Martin-Lorenzo, Marta
Alvarez-Llamas, Gloria
author_sort Santiago-Hernandez, Aranzazu
collection PubMed
description Atherosclerosis is the predominant pathology associated to premature deaths due to cardiovascular disease. However, early intervention based on a personalized diagnosis of cardiovascular risk is very limited. We have previously identified metabolic alterations during atherosclerosis development in a rabbit model and in subjects suffering from an acute coronary syndrome. Here we aim to identify specific metabolic signatures which may set the basis for novel tools aiding cardiovascular risk diagnosis in clinical practice. In a cohort of subjects with programmed coronary artery bypass grafting (CABG), we have performed liquid chromatography and targeted mass spectrometry analysis in urine and plasma. The role of vascular smooth muscle cells from human aorta (HA-VSMCs) was also investigated by analyzing the intra and extracellular metabolites in response to a pro-atherosclerotic stimulus. Statistically significant variation was considered if p value < 0.05 (Mann-Whitney test). Urinary trimethylamine N-oxide (TMAO), arabitol and spermidine showed higher levels in the CVrisk group compared with a control group; while glutamine and pantothenate showed lower levels. The same trend was found for plasma TMAO and glutamine. Plasma choline, acetylcholine and valine were also decreased in CVrisk group, while pyruvate was found increased. In the secretome of HA-VSMCs, TMAO, pantothenate, glycerophosphocholine, glutathion, spermidine and acetylcholine increased after pro-atherosclerotic stimulus, while secreted glutamine decreased. At intracellular level, TMAO, pantothenate and glycerophosphocholine increased with stimulation. Observed metabolic deregulations pointed to an inflammatory response together with a deregulation of oxidative stress counteraction.
format Online
Article
Text
id pubmed-8466954
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-84669542021-09-27 Metabolic Alterations Identified in Urine, Plasma and Aortic Smooth Muscle Cells Reflect Cardiovascular Risk in Patients with Programmed Coronary Artery Bypass Grafting Santiago-Hernandez, Aranzazu Martinez, Paula J. Agudiez, Marta Heredero, Angeles Gonzalez-Calero, Laura Yuste-Montalvo, Alma Esteban, Vanesa Aldamiz-Echevarria, Gonzalo Martin-Lorenzo, Marta Alvarez-Llamas, Gloria Antioxidants (Basel) Article Atherosclerosis is the predominant pathology associated to premature deaths due to cardiovascular disease. However, early intervention based on a personalized diagnosis of cardiovascular risk is very limited. We have previously identified metabolic alterations during atherosclerosis development in a rabbit model and in subjects suffering from an acute coronary syndrome. Here we aim to identify specific metabolic signatures which may set the basis for novel tools aiding cardiovascular risk diagnosis in clinical practice. In a cohort of subjects with programmed coronary artery bypass grafting (CABG), we have performed liquid chromatography and targeted mass spectrometry analysis in urine and plasma. The role of vascular smooth muscle cells from human aorta (HA-VSMCs) was also investigated by analyzing the intra and extracellular metabolites in response to a pro-atherosclerotic stimulus. Statistically significant variation was considered if p value < 0.05 (Mann-Whitney test). Urinary trimethylamine N-oxide (TMAO), arabitol and spermidine showed higher levels in the CVrisk group compared with a control group; while glutamine and pantothenate showed lower levels. The same trend was found for plasma TMAO and glutamine. Plasma choline, acetylcholine and valine were also decreased in CVrisk group, while pyruvate was found increased. In the secretome of HA-VSMCs, TMAO, pantothenate, glycerophosphocholine, glutathion, spermidine and acetylcholine increased after pro-atherosclerotic stimulus, while secreted glutamine decreased. At intracellular level, TMAO, pantothenate and glycerophosphocholine increased with stimulation. Observed metabolic deregulations pointed to an inflammatory response together with a deregulation of oxidative stress counteraction. MDPI 2021-08-27 /pmc/articles/PMC8466954/ /pubmed/34573001 http://dx.doi.org/10.3390/antiox10091369 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Santiago-Hernandez, Aranzazu
Martinez, Paula J.
Agudiez, Marta
Heredero, Angeles
Gonzalez-Calero, Laura
Yuste-Montalvo, Alma
Esteban, Vanesa
Aldamiz-Echevarria, Gonzalo
Martin-Lorenzo, Marta
Alvarez-Llamas, Gloria
Metabolic Alterations Identified in Urine, Plasma and Aortic Smooth Muscle Cells Reflect Cardiovascular Risk in Patients with Programmed Coronary Artery Bypass Grafting
title Metabolic Alterations Identified in Urine, Plasma and Aortic Smooth Muscle Cells Reflect Cardiovascular Risk in Patients with Programmed Coronary Artery Bypass Grafting
title_full Metabolic Alterations Identified in Urine, Plasma and Aortic Smooth Muscle Cells Reflect Cardiovascular Risk in Patients with Programmed Coronary Artery Bypass Grafting
title_fullStr Metabolic Alterations Identified in Urine, Plasma and Aortic Smooth Muscle Cells Reflect Cardiovascular Risk in Patients with Programmed Coronary Artery Bypass Grafting
title_full_unstemmed Metabolic Alterations Identified in Urine, Plasma and Aortic Smooth Muscle Cells Reflect Cardiovascular Risk in Patients with Programmed Coronary Artery Bypass Grafting
title_short Metabolic Alterations Identified in Urine, Plasma and Aortic Smooth Muscle Cells Reflect Cardiovascular Risk in Patients with Programmed Coronary Artery Bypass Grafting
title_sort metabolic alterations identified in urine, plasma and aortic smooth muscle cells reflect cardiovascular risk in patients with programmed coronary artery bypass grafting
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8466954/
https://www.ncbi.nlm.nih.gov/pubmed/34573001
http://dx.doi.org/10.3390/antiox10091369
work_keys_str_mv AT santiagohernandezaranzazu metabolicalterationsidentifiedinurineplasmaandaorticsmoothmusclecellsreflectcardiovascularriskinpatientswithprogrammedcoronaryarterybypassgrafting
AT martinezpaulaj metabolicalterationsidentifiedinurineplasmaandaorticsmoothmusclecellsreflectcardiovascularriskinpatientswithprogrammedcoronaryarterybypassgrafting
AT agudiezmarta metabolicalterationsidentifiedinurineplasmaandaorticsmoothmusclecellsreflectcardiovascularriskinpatientswithprogrammedcoronaryarterybypassgrafting
AT herederoangeles metabolicalterationsidentifiedinurineplasmaandaorticsmoothmusclecellsreflectcardiovascularriskinpatientswithprogrammedcoronaryarterybypassgrafting
AT gonzalezcalerolaura metabolicalterationsidentifiedinurineplasmaandaorticsmoothmusclecellsreflectcardiovascularriskinpatientswithprogrammedcoronaryarterybypassgrafting
AT yustemontalvoalma metabolicalterationsidentifiedinurineplasmaandaorticsmoothmusclecellsreflectcardiovascularriskinpatientswithprogrammedcoronaryarterybypassgrafting
AT estebanvanesa metabolicalterationsidentifiedinurineplasmaandaorticsmoothmusclecellsreflectcardiovascularriskinpatientswithprogrammedcoronaryarterybypassgrafting
AT aldamizechevarriagonzalo metabolicalterationsidentifiedinurineplasmaandaorticsmoothmusclecellsreflectcardiovascularriskinpatientswithprogrammedcoronaryarterybypassgrafting
AT martinlorenzomarta metabolicalterationsidentifiedinurineplasmaandaorticsmoothmusclecellsreflectcardiovascularriskinpatientswithprogrammedcoronaryarterybypassgrafting
AT alvarezllamasgloria metabolicalterationsidentifiedinurineplasmaandaorticsmoothmusclecellsreflectcardiovascularriskinpatientswithprogrammedcoronaryarterybypassgrafting